International Journal of
Genetics and Molecular Biology

  • Abbreviation: Int. J. Genet. Mol. Biol.
  • Language: English
  • ISSN: 2006-9863
  • DOI: 10.5897/IJGMB
  • Start Year: 2009
  • Published Articles: 131

Full Length Research Paper

Bael, Aegle marmelos (L.) Correa, an Indian medicinal plant protects V79 cells against the genotoxic effect of doxorubicin

Ganesh Chandra Jagetia
  • Ganesh Chandra Jagetia
  • Department of Zoology, Mizoram University, Tanhril, Aizawl-796 0094, India.
  • Google Scholar
Ponemone Venkatesh
  • Ponemone Venkatesh
  • Department of Zoology, Mizoram University, Tanhril, Aizawl-796 0094, India.
  • Google Scholar


  •  Received: 28 June 2011
  •  Accepted: 25 June 2015
  •  Published: 30 July 2015

References

Abraham R, Basser RL, Green MD (1996). A risk-benefit assessment of anthracycline antibiotics in antineoplastic therapy. Drug Safety 15:406-429.
Crossref

 

Al-Harbi MM (1993). Effect of captopril on the cytological and biochemical changes induced by adriamycin. Food Chem. Toxicol. 31: 209-212.
Crossref

 

 

Al-Shabanah OA (1993). Inhibition of adriamycin-induced micronuclei by desferrioxamine in Swiss albino mice. Mutat. Res. 301:107-111.
Crossref

 

 

Antunes LM, Takahashi CS (1998). Effects of high doses of vitamins C and E against doxorubicin-induced chromosomal damage in Wistar rat bone marrow cells. Mutat. Res. 419:137-143.
Crossref

 

 

Antunes LM, Takahashi CS (1999). Protection and induction of chromosomal damage by vitamin C in human lymphocyte cultures.Teratog. Carcinog. Mutagen. 19:53-59.
Crossref

 

 

Babudri N, Pani B, Tamaro M, Monti-Bragadin C, Zunino F (1984). Related Articles, Mutagenic and cytotoxic activity of doxorubicin and daunorubicin derivatives on prokaryotic and eukaryotic cells. Br. J. Cancer 50:91-96.
Crossref

 

 

Baker ES, Connor TH (1996). Monitoring occupational exposure to cancer chemotherapy drugs. Am. J. Health Syst. Pharmacol. 53: 2713–2723.

 

 

Bardeleben RV, Dunkern T, Kaina B, Fritz G (2002). The HMG-CoA reductase inhibitor lovastatin protects cells from the antineoplastic drugs doxorubicin and etoposide. Int. J. Mol. Med. 10: 473-479.
Crossref

 

 

Bean CL, Armstrong MJ, Galloway SM (1992). Effect of sampling time on chromosome aberration yield for 7 chemicals in Chinese hamster ovary cells. Mutat. Res. 265:31-44.
Crossref

 

 

Bhuyan BK, Zimmer DM, Mazurek JH, Trzos RJ, Harbach PR, Shu VS, Johnson MA (1983). Related Articles, Comparative genotoxicity of adriamycin and menogarol, two anthracycline antitumor agents. Cancer Res. 43: 5293-5297.

 

 

Bogdanović G, Kojić V, Dordević A, Canadanović-Brunet J, Vojinović-Miloradov M, Baltić VV. (2004) Modulating activity of fullerol C60(OH)22 on doxorubicin-induced cytotoxicity.Toxicol. InVitro. 18(5):629-637.
Crossref

 

 

Bonner JA, Lawrence (1989). TS Protection of doxorubicin cytotoxicity by cycloheximide. Int. J. Radiat. Oncol. Biol. Phys. 16:1209-1212.
Crossref

 

 

Boucher R, Livingston GK, Que Hee SS (1993). In vitro micronucleus bioassay of human peripheral lymphocytes for adriamycin in the presence of cyclophosphamide and urines of patients administered anticancer drugs. Environ. Mol. Mutagen. 21:372-382.
Crossref

 

 

Carter SK (1975). Adriamycin – A review. J. Natl. Cancer Inst. 55:1265-1274.

 

 

Chen SH, Chan NL, Hsieh TS (2013). New mechanistic and functional insights into DNA topoisomerases .Annu Rev Biochem. 82:139-147
Crossref

 

 

De Graff WG, Myers Jr LS, Mitchell JB, Hahn SM (2003). Protection against Adriamycin cytotoxicity and inhibition of DNA topoisomerase II activity by 3, 4-dihydroxybenzoic acid. Int. J. Oncol. 23:159-163.
Crossref

 

 

Delvaeye M, Verovski V, De Neve W, Storme G (1993). DNA breakage, cytotoxicity, drug accumulation and retention in two human ovarian tumor cell lines AZ224 and AZ364 treated with adriamycin, modulated by verapamil. Anticancer Res. 13: 1533-1538.

 

 

Dhawan A, Kayani MA, Parry JM, Parry E, Anderson D (2003). Aneugenic and clastogenic effects of doxorubicin in human lymphocytes. Mutagenesis 18:487-490.
Crossref

 

 

Dulout FN, Larramendy ML, Olivero OA (1981). Effect of caffeine on the frequency of chromosome aberrations induced in vivo by triethylenemelamine (TEM) and adriamycin (ADR) in mice. Mutat. Res. 82:295-304.
Crossref

 

 

Fenech M, Morley AA (1985). Measurement of micronuclei in lymphocytes. Mutat. Res. 147:29-36.
Crossref

 

 

Fenech M, Kirsch-Volders M, Natarajan AT, Surralles J, Crott JW, Parry J, Norppa H, Eastmond DA, Tucker JD, Thomas P (2011) Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis. (1):125-32.
Crossref

 

 

Gewirtz DA (1999). A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 57:727-741.
Crossref

 

 

Guano F, Pourquier P, Tinelli S, Binaschi M, Bigioni M, Animati F, Manzini S, Zunino F, Kohlhagen G, Pommier Y, Capranico G (1999). Topoisomerase poisoning activity of novel disaccharide anthracyclines. Mol. Pharmacol. 56:77-84.

 

 

Gumulec J, Fojtu M, Raudenska M, Sztalmachova M, Skotakova A, Vlachova J, Skalickova S, Nejdl L, Kopel P, Knopfova L0, Adam V, KizekR,Stiborova M, Babula P, Masarik M (2014) Modulation of induced cytotoxicity of doxorubicin by using apoferritin and liposomal cages. Int. J. Mol. Sci. 15(12):22960-22977
Crossref

 

 

Heddle JA, Hite M, Kirkhart B, Mavournin K, MacGregor JT, Newell GW, Salamone MF (1983). The induction of micronuclei as a measure of genotoxicity. A report of the U.S. Environmental Protection Agency Gene-Tox. Program. Mutat. Res. 123:61-118.
Crossref

 

 

Helbig R, Speit G (1995). The pattern of adriamycin-induced mutations in V-E5 Chinese hamster cells with chromosomal instability. Mutat. Res. 348:1-6.
Crossref

 

 

Hozayen WG (2012). Effect Of Hesperidin and Rutin On Doxorubicin Induced Testicular Toxicity in Male Rats. Int. J. Food. Nutrit.Sci., 1(1):31-42.

 

 

Iliakis G, Lazar W (1987). Reduction by caffeine of adriamycin-induced cell killing and DNA damage in Chinese hamster cells: correlation with modulation in intracellular adriamycin content. Cancer Res. 47: 2224-2229.

 

 

Jagetia GC, Baliga MS (2002). Syzygium cumini (Jamun) reduces the radiation-induced DNA damage in the cultured human peripheral blood lymphocytes: a preliminary study. Toxicol. Lett. 132: 19-25.
Crossref

 

 

Jagetia GC, Reddy TK (2014) The grape fruit flavononenaringin protects mice against doxorubicin-induced cardiotoxicity. J. Mol. Biochem. 3:34-49.

 

 

Jagetia GC (2008). Cardioprotection by Bael. Recent Progress in Medicinal Plants: Phytopharmacology and Therapeutic values. 20 Edited by Govil JN, Singh VK, Mishra SK Studium Press LLC, Houston USA pp 147-162.

 

 

Jagetia GC, Adiga SK (1998). Influence of vindesine exposure on the micronucleus formation and cell survival in V79 cells. Mutat. Res. 421:55-63.
Crossref

 

 

Jagetia GC, Aruna R (1997). The herbal preparation abana protects against radiation-induced micronuclei in mouse bone marrow. Mutat. Res. 393:157-163.
Crossref

 

 

Jagetia GC, Aruna R (2000). Correlation between cell survival and micronuclei-induction in HeLa cells treated with adriamycin after exposure to various doses of gamma-radiation. Toxicol. Lett. 115: 183-193.
Crossref

 

 

Jagetia GC, Ganapathi NG (1989). Inhibition of clastogenic effect of radiation by Liv. 52 in the bone marrow of mice. Mutat. Res. 224:507-510.
Crossref

 

 

Jagetia GC, Nayak V (1996). Micronuclei-induction and its correlation to cell survival in HeLa cells treated with different doses of adriamycin. Cancer Lett. 110: 123-128.
Crossref

 

 

Jagetia GC, Nayak V (2000). Effect of doxorubicin on cell survival and micronuclei formation in HeLa cells exposed to different doses of gamma-radiation. Strahlenther Onkol. 176:422-428.
Crossref

 

 

Jagetia GC, Venkatesh P (2005). Radioprotection by oral administration of Aegle marmelos (L.) Correa in vivo. J. Environ. Pathol. Toxicol. Oncol. 24: 315-332.
Crossref

 

 

Jagetia GC, Venkatesh P (2007). Inhibition of radiation-induced clastogenicity by Aegle marmelos (L.) correa in mice bone marrow exposed to different doses of gamma-radiation. Hum. Exp. Toxicol. 26: 111-24.
Crossref

 

 

Jagetia GC, Venkatesha VA (2005). Effect of mangiferin on radiation-induced micronucleus formation in cultured human peripheral blood lymphocytes. Environment Molec. Mutagen. 46:12-21.
Crossref

 

 

Jagetia GC, Venkatesh P, Baliga MS (2003). Evaluation of the radioprotective effect of Aegle marmelos (L.) Correa in cultured human peripheral blood lymphocytes exposed to different doses of gamma-radiation: a micronucleus study. Mutagenesis 18: 387-393.
Crossref

 

 

Jagetia GC, Venkatesh P, Baliga MS (2004). Evaluation of the radioprotective effect of bael leaf (Aegle marmelos) extract in mice. Int. J. Radiat. Biol. 80:281-290.
Crossref

 

 

Kato FH, Viana NI, Santini CB, de Souza CG, Veneziani RC, Ambrósio SR, Tavares DC (2012). Assessment of the in vitro and in vivo genotoxic and antigenotoxic effects of pimaradienoic acid in mammalian cells. Mutat. Res. 749(1-2):87-92.
Crossref

 

 

Kinghorn AD, Farnsworth NR, Soejarto DD, Cordell GA, Swanson SM, Pezzuto SM, Wani MC, Wall ME, Oberlies NH, Kroll DJ, Kramer RA, Rose WC, Vite GD, Fairchild CR, Peterson RW, Wild R (2003). Novel strategies for the discovery of plant-derived anticancer agents. Pharmaceut. Biol. 41 Suppl: 53-67.
Crossref

 

 

Kirsch-Volders M, Sofuni T, Aardema M, Albertini S, Eastmond D, Fenech M, Ishidate M Jr, Kirchner S, Lorge E, Morita T, Norppa H, Surrallés J, Vanhauwaert A, Wakata A. (2003) Report from the in vitro micronucleus assay working group. Mutat Res. 540(2):153-163.
Crossref

 

 

Kiyomiya K, Matsuo S, Kurebe M (2001). Differences in intracellular sites of action of Adriamycin in neoplastic and normal differentiated cells. Cancer Chemother. Pharmacol. 47:51-56.
Crossref

 

 

Korina LG, Afanas'ev IB (1997). Antioxidant and chelating properties of flavonoids. Adv. Pharmacol. 38:151-163.
Crossref

 

 

López-Alarcón C, Denicola A (2013). Evaluating the antioxidant capacity of natural products: A review on chemical and cellular-based assays. Analytica Chimica Acta 763:1-10.
Crossref

 

 

Majer BJ, Laky B, Knasmuller S, Kassie F (2001). Use of the micronucleus assay with exfoliated epithelial cells as a biomarker for monitoring individuals at elevated risk of genetic damage and in chemoprevention trials. Mutat. Res. 489(2-3): 147-172.
Crossref

 

 

Martin WM and McNally NJ (1980). Cytotoxicity of adriamycin to tumour cells in vivo and in vitro. Br. J. Cancer 42:881-889.
Crossref

 

 

Minotti G, Recalcati S, Menna P, Salvatorelli E, Corna G, Cairo G (2004). Doxorubicin cardiotoxicity and the control of iron metabolism: quinone-dependent and independent mechanisms. Methods Enzymol. 378: 340-361.
Crossref

 

 

Mosmann T (1983). Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65:55-63.
Crossref

 

 

Nadkarni AK (1976). Indian Materia Medica, Ed 3. Popular Press Ltd. Mumbai India.

 

 

Nitiss JL (2009) Targeting DNA topoisomerase II in cancer chemotherapy.Nat. Rev. Cancer 9(5):338-50.
Crossref

 

 

Pendleton M, Lindsey RH Jr, Felix CA, Grimwade D, Osheroff N (2014). Topoisomerase II and leukemia. Ann N Y Acad Sci. 1310:98-110.
Crossref

 

 

Pérez-Arnaiz C, Busto N, Leal JM, García B (2014). New insights into the mechanism of the DNA/doxorubicin interaction. J Phys Chem B. 118(5):1288-95.
Crossref

 

 

Pletz N, Schön M, Ziegelbauer K, Emmert S, Liu N, Dobbelstein M, Schön MP (2012). Doxorubicin-induced activation of NF-κB in melanoma cells is abrogated by inhibition of IKKβ, but not by a novel IKKα inhibitor. Exp. Dermatol. 21(4):301-304.
Crossref

 

 

Pommier Y, Schwartz RE, Zwelling LA, Kohn KW (1985). Effects of DNA intercalating agents on topoisomerase II induced DNA strand cleavage in isolated mammalian cell nuclei. Biochemistry 24:6406-6410.
Crossref

 

 

Powis G (1989). Free radical formation by antitumor quinones. Free Radical Biol. Med. 6:63-101.
Crossref

 

 

Puck TT, Marcus PI (1955). A rapid method for viable cell titration and clone production with HeLa cells in tissue culture. The use of X-irradiated cells to supply conditioning factors. Proc. Natl. Acad. Sci. USA 41:432-437.
Crossref

 

 

Rahman S, Parvin R (2014) Therapeutic potential of Aegle marmelos (L.)-An overview Asian Pac J Trop Dis 4(1):71-77.
Crossref

 

 

Rastogi RM, Mehrotra BN (1990). Compendium of Indian medicinal plants (Central drug research Institute Lucknow India) 1: 388-389.

 

 

Rice-Evans CA, Miller NJ, Bolwell PG, Bramley PM, Pridham JB (1995). The relative antioxidant activities of plant-derived polyphenolic flavonoids. Free Radic. Res. 22:375-383.
Crossref

 

 

Russell NS, Arlett CF, Bartelink H, Begg AC (1995). Use of fluorescence in situ hypbridization to determine the relationship between chromosome aberrations and cell survival in eight human fibroblast strains. Int. J. Radiat. Biol. 68: 185-196.
Crossref

 

 

Sato Y, Sasaki N, Saito M, Endo N, Kugawa F, Ueno A (2015) Luteolin attenuates Doxorubicin-induced cytotoxicity to mcf-7 human breast cancer cells. Biol. Pharm. Bull. 38(5):703-709.
Crossref

 

 

Schneider E, Hsiang Y, Liu LF (1990). DNA topoisomerases as anticancer drug targets. Adv. Pharmacol. 21:149-183.
Crossref

 

 

Shibamoto Y, Streffer C, Fuhrmann C, Budach V (1991). Tumor radiosensitivity prediction by the cytokinesis-block micronucleus assay. Radiat. Res. 128:293-300.
Crossref

 

 

Sugamura K, Keaney J F Jr. (2011). Reactive oxygen species in cardiovascular disease. Free Radic. Med. 51:978-992.
Crossref

 

 

Suter W, Brennand J, McMillan S, Fox M (1980). Relative mutagenicity of antineoplastic drugs and other alkylating agents in V79 Chinese hamster cells, independence of cytotoxic and mutagenic responses. Mutat. Res. 73: 171-181.
Crossref

 

 

Tacar O, Sriamornsak P, Dass CR (2013). Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems. J Pharm Pharmacol 65(2) 157-170
Crossref

 

 

Tewey KM, Rowe TC, Yang L, Halligan BD, Liu LF (1984). Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II. Science 226: 466–468.
Crossref

 

 

Van Acker S, Van den Berg DJ, Tromp MNJL, Griffioen DH, Van Bennekom WP, Van der Vijgh WJF, Bast A (1996). Structural aspects of antioxidant activity of flavonoids. Free Radic. Biol. Med. 20: 331-342.
Crossref

 

 

Venkatesh P, Shantala B, Jagetia GC, Rao KK, Baliga MS (2007). Modulation of doxorubicin-induced genotoxicity by Aegle marmelos in mouse bone marrow: a micronucleus study. Integr. Cancer Ther. 6:42-53.
Crossref

 

 

Wandl EO, Ono K, Kain R, Herbsthofer T, Hienert G, Hobarth K (1989). Linear correlation between surviving fraction and the micronucleus frequency. Int. J. Radiat. Biol. 56: 771-775.
Crossref

 

 

Wang S, Kotamraju S, Konorev E, Kalivendi S, Joseph J, Kalyanaraman B (2002). Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide. Biochem. J. 367: 729-740.
Crossref

 

 

Weiss JF, Landauer MR (2003). Protection against ionizing radiation by antioxidant nutrients and phytochemicals. Toxicology 189:1-20.
Crossref

 

 

Wu X, Mao Y (2012). Effect of catalpol on doxorubicin-induced cytotoxicity in H9c2 cells. J. Med. Plants Res. 6(5):849-854.

 

 

Yates LR, Campbell PJ (2012). Evolution of the cancer genome. Nature Rev. Genet. 13:795-806.
Crossref